Gordon K.H. Chu , Emily M. Lee , James K.Y. Hooi , Jane C.Y. Wong , Valerie Chiang , Philip H. Li
{"title":"COVID-19大流行后香港的免疫学和过敏转诊模式：一项8年的纵向分析","authors":"Gordon K.H. Chu , Emily M. Lee , James K.Y. Hooi , Jane C.Y. Wong , Valerie Chiang , Philip H. Li","doi":"10.1016/j.jahd.2024.100023","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>In 2018, Hong Kong established its first public adult clinical immunology and allergy (IA) team. The COVID-19 outbreak in early 2020 disrupted services for IA patients. This study aims to assess case burden among non-COVID-19-related referrals at our center before and after the COVID-19 pandemic and identify changing service needs.</div></div><div><h3>Methods</h3><div>The study included the first 1000 adult patients seen at our clinic, divided into “pre-COVID-19” (Jan 2018–Dec 2019) and “post-COVID-19” (Jan 2020–Dec 2022) groups. Clinical data were compared between these cohorts.</div></div><div><h3>Results</h3><div>Of the first 1000 cases, allergy and immunology cases were equally represented. There was a significant increase in allergy referrals in the post-COVID19 cohort, particularly a 7 % rise in drug allergy cases. Conversely, immunology referrals decreased significantly.</div></div><div><h3>Conclusion</h3><div>Referral trends shifted towards allergy cases, especially drug allergies, after COVID-19. It is essential to implement effective protocols to manage the increased allergy burden and enable primary care providers to handle low-risk cases.</div></div>","PeriodicalId":100752,"journal":{"name":"Journal of Allergy and Hypersensitivity Diseases","volume":"3 ","pages":"Article 100023"},"PeriodicalIF":0.0000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Immunology & Allergy referral patterns in Hong Kong following the COVID-19 pandemic: A 8-year longitudinal analysis\",\"authors\":\"Gordon K.H. Chu , Emily M. Lee , James K.Y. Hooi , Jane C.Y. Wong , Valerie Chiang , Philip H. Li\",\"doi\":\"10.1016/j.jahd.2024.100023\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>In 2018, Hong Kong established its first public adult clinical immunology and allergy (IA) team. The COVID-19 outbreak in early 2020 disrupted services for IA patients. This study aims to assess case burden among non-COVID-19-related referrals at our center before and after the COVID-19 pandemic and identify changing service needs.</div></div><div><h3>Methods</h3><div>The study included the first 1000 adult patients seen at our clinic, divided into “pre-COVID-19” (Jan 2018–Dec 2019) and “post-COVID-19” (Jan 2020–Dec 2022) groups. Clinical data were compared between these cohorts.</div></div><div><h3>Results</h3><div>Of the first 1000 cases, allergy and immunology cases were equally represented. There was a significant increase in allergy referrals in the post-COVID19 cohort, particularly a 7 % rise in drug allergy cases. Conversely, immunology referrals decreased significantly.</div></div><div><h3>Conclusion</h3><div>Referral trends shifted towards allergy cases, especially drug allergies, after COVID-19. It is essential to implement effective protocols to manage the increased allergy burden and enable primary care providers to handle low-risk cases.</div></div>\",\"PeriodicalId\":100752,\"journal\":{\"name\":\"Journal of Allergy and Hypersensitivity Diseases\",\"volume\":\"3 \",\"pages\":\"Article 100023\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Allergy and Hypersensitivity Diseases\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S295031242400023X\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Allergy and Hypersensitivity Diseases","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S295031242400023X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Immunology & Allergy referral patterns in Hong Kong following the COVID-19 pandemic: A 8-year longitudinal analysis
Background
In 2018, Hong Kong established its first public adult clinical immunology and allergy (IA) team. The COVID-19 outbreak in early 2020 disrupted services for IA patients. This study aims to assess case burden among non-COVID-19-related referrals at our center before and after the COVID-19 pandemic and identify changing service needs.
Methods
The study included the first 1000 adult patients seen at our clinic, divided into “pre-COVID-19” (Jan 2018–Dec 2019) and “post-COVID-19” (Jan 2020–Dec 2022) groups. Clinical data were compared between these cohorts.
Results
Of the first 1000 cases, allergy and immunology cases were equally represented. There was a significant increase in allergy referrals in the post-COVID19 cohort, particularly a 7 % rise in drug allergy cases. Conversely, immunology referrals decreased significantly.
Conclusion
Referral trends shifted towards allergy cases, especially drug allergies, after COVID-19. It is essential to implement effective protocols to manage the increased allergy burden and enable primary care providers to handle low-risk cases.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
